iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study
NCT ID: NCT04624685
Last Updated: 2021-10-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
475 participants
OBSERVATIONAL
2020-01-15
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to understand study requirements
* Willing to attend scheduled follow-up exams for 5 years post-operatively
* Able and willing to provide written informed consent on the IRB approved Informed Consent Form
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Glaukos Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arizona Advanced Eye Research Institute
Glendale, Arizona, United States
Vold Vision, PLLC
Fayetteville, Arkansas, United States
North Bath Eye Associates, Inc.
Santa Rosa, California, United States
Eye Center of northern Colorado, PC
Fort Collins, Colorado, United States
Argus Research
Cape Coral, Florida, United States
International Research Center
Tampa, Florida, United States
Center for Sight
Venice, Florida, United States
Clayton Eye Clinical Research, LLC.
Morrow, Georgia, United States
Chicago Eye Specialists
Chicago, Illinois, United States
Arbor Center for Eye Care
Orland Park, Illinois, United States
Stiles Eyecare Excellence
Overland Park, Kansas, United States
D'Ambrosio Eye Care
Lancaster, Massachusetts, United States
Kresge Eye Institute / Wayne State University
Detroit, Michigan, United States
Discover Vision Centers
Independence, Missouri, United States
Northern New Jersey Eye Institute
South Orange, New Jersey, United States
Glaucoma Consultants of the Capital Region
Slingerlands, New York, United States
Oklahoma eye Surgeons, PLLC
Oklahoma City, Oklahoma, United States
Keystone Research
Austin, Texas, United States
Ophthalmology Associates
Fort Worth, Texas, United States
Parkhurst Nuvision
San Antonio, Texas, United States
R and R Eye Resarch, LLC
San Antonio, Texas, United States
Vistar Eye Center
Roanoke, Virginia, United States
Spokane Eye Clinical Research
Spokane, Washington, United States
The Eye Center of Racine and Kenosha
Racine, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IG2M-104-CONT
Identifier Type: -
Identifier Source: org_study_id